Digital Pathology Market Size, Share, Industry Growth, Analysis and Forecast 2028
                     Digital Pathology Market 
Digital Pathology Market Forecast to 2028 
- COVID-19 Impact and Global Analysis By 
Product (Scanners, Software, Storage, and 
Communication Systems), Type (Human 
Pathology and Veterinary Pathology), 
Application (Drug Discovery, Disease 
Diagnostics, Teleconsultation, and Training 
& Education), and End User (Pharma and 
Biotech Companies, Hospitals, and 
Academics) 
Digital Pathology Market 
Market Insights
 Technological Advancements in Digital Pathology Systems Boosts Digital Pathology Market
 Computerization, robotic light microscopy, multiple fiber-optic communications, and digital imaging are among the technologies 
contributing to the modernization of digital pathology. Healthcare information technology (IT) helps physicians in maintaining optimal 
workflow, along with allowing them to meet the continuously changing patient expectations.
 The Aperio ePathAccess software offered by Leica Biosystems enables users to share digital pathology images and case data with experts 
outside the IT network. Further, frequent advancements in whole-slide imaging (WSI) technology, software applications, LIS/LIMS 
interface, and high-speed networking are allowing pathologists to fully integrate digital pathology into their workflows.
 Further, the growing use of microarrays  and predictive models, such as API algorithms and hybrid models, is bolstering the demand for 
digital image analysis. A computer-aided diagnosis integrates image processing with the concepts of physics and mathematics, and 
computational algorithms for disease diagnosis, anatomical evaluation, and disease progression quantification and risk assessment.
 Thus, the increasing popularity of computer-aided systems is supporting the digital pathology market growth.
Key Findings
 Product Insights
 Based on product, the digital pathology market is segmented into scanner, software, storage, and communication 
system. The scanner segment is further bifurcated into integrated and standalone. The scanner segment held the 
largest market share in 2022. However, the software segment is expected to register the highest CAGR during the 
forecast period. Digital pathology software solutions are used for image analysis and data restoring.
 Companies such as Visiopharm and Indica Labs provide software and solutions for digital pathology.
 Type Insights
 Based on type, the digital pathology market is bifurcated into human pathology and veterinary pathology. The human 
pathology segment is likely to hold a larger market share in 2022. Furthermore, the same segment is expected to 
record a faster CAGR during 2022–2028. The market for the human pathology segment is driven by the increasing 
number of cancer research projects and a rising number of collaborations among research institutes, universities, and 
pathology laboratories.
Digital Pathology Market 
 
Market Segments
By Product By Application 
Scanners Drug Discovery By End User 
Software Disease Diagnostics Pharma and Biotech Companies
Storage and Communication Systems Teleconsultation and Training & Hospitals and Academics
Education
Digital Pathology Market 
Dominating Segments
 
 
 Application Insights
 Based on application, the digital pathology market is segmented into disease diagnosis, drug discovery, 
teleconsultation, and training & education. The drug discovery segment is likely to hold the largest market 
share in 2022. 
 Furthermore, the same segment is expected to record the highest CAGR during 2022–2028. The central 
benefit of digital pathology in pharmaceutical research is the ability to apply image analysis algorithms to 
reduce time and efforts required for subject interpretations. 
 This is critically important to automate dull tasks such as counting cells of interest or estimating protein 
expression in immunohistochemical assays.
Dominating Segments
Product Insights
End User Insights
 Based on end user, the digital pathology market is segmented into pharma & biotech companies, hospitals, and academics. In 
2022, the pharma & biotech companies segment is likely to hold the largest share of the market. Furthermore, the same 
segment is expected to register the highest CAGR from 2022 to 2028. 
 The increasing use of digital pathology in drug discovery studies and drug toxicology testing is the major factor driving the 
market for the pharma & biotech companies segment. Biotechnology companies also use digital pathology in biobanking, 
biopharmaceutical studies, molecular assays, and individualized medicine development.
 Download PDF Brochure:- https://www.theinsightpartners.com/sample/TIPHE100000855/  
Digital Pathology Market  
Leading Players
The List of Companies - Digital Pathology Market
Koninklijke Philips N.V.
Nikon Corporation
Perkin Elmer, Inc.
Indica Labs
3DHISTECH Ltd.
Hamamatsu Photonics K.K.
F. Hoffmann-La Roche Ltd
Visiopharm A/S
Glencoe Software, Inc.
Danaher Corporation
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
Digital Pathology Market  
 
 
 Digital Pathology Market
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/digital-pathology-market 
 
Thank You! 
Thank You!